Study endpoints
The primary endpoint of this study was a composite of major adverse
cardiac and cerebrovascular events (defined as ischemic stroke,
hemorrhagic stroke, TIA, cardiovascular events including hospitalization
for heart failure, acute coronary syndrome, and other cardiovascular
events and all-cause death). Such events occurring within 3 months after
the procedure were considered procedure-related adverse events and were
excluded from the endpoint.